Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro study - 21/08/11
Résumé |
Background |
The active metabolite of clopidogrel binds the P2Y12 ADP receptor on the platelet surface via a disulfide bond. N-Acetylcysteine (NAC) is able to reduce disulfide bonds. We postulated that NAC might reverse clopidogrel's effect on platelets.
Methods |
Two groups of patients were investigated. Group 1 included 11 patients with stable coronary disease who, after discontinuation of aspirin, received 14 days of clopidogrel, 75 mg/day. Bleeding time and whole-blood platelet aggregometry (with 5 μmol/L ADP) were compared before and after the 14 days. Patients were then treated with 6 g of NAC orally, followed by repeat measurement of bleeding time and aggregometry.
In group 2, 14 patients were treated with clopidogrel (300 mg) and aspirin before a percutaneous coronary intervention. Blood was drawn 22 ± 3 hours later and divided into 2 samples. One was sent immediately for platelet-rich plasma aggregometry (using 5 and 2 μmol/L ADP, collagen, and arachidonic acid as agonists), thromboelastography, and aggregometry using the Plateletworks assay (Helena Laboratories, Beaumont, Tex). The other sample was treated with NAC (500 mg/L), after which these same platelet function tests were performed.
Results |
In group 1, NAC therapy did not significantly change the bleeding time or results of aggregometry. In group 2, neither aggregometry nor the Plateletworks assay suggested reversal of inhibition by NAC.
Conclusions |
These studies reveal that a large dose of NAC does not reduce inhibition of platelet aggregation by clopidogrel in vitro or in vivo.
Le texte complet de cet article est disponible en PDF.Plan
| Supported in part by a grant from the Surgeon General of the United States Air Force and an unrestricted educational grant from the Sanofi-Synthelabo/Bristol-Meyers Squibb Partnership |
Vol 150 - N° 4
P. 796-799 - octobre 2005 Retour au numéro
Article précédent
- Protective effect of high diastolic blood pressure during exercise against exercise-induced myocardial ischemia
- Hiroyuki Yamagishi, Minoru Yoshiyama, Naoya Shirai, Kaname Akioka, Kazuhide Takeuchi, Junichi Yoshikawa
- Association between completeness of percutaneous coronary revascularization and postprocedure outcomes
- Catherine S. McLellan, William A. Ghali, Marino Labinaz, Roger B. Davis, P. Diane Galbraith, Danielle A. Southern, Fiona M. Shrive, Merril L. Knudtson, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Investigators e
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?